𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of Alzheimer's disease with acetylcholinesterase inhibitors: bridging the gap between evidence and practice

✍ Scribed by Giovanni B. Frisoni

Publisher
Springer
Year
2001
Tongue
English
Weight
211 KB
Volume
248
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The efficacy of galantamine in the treat
The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure
✍ J. E. Mintzer; P. Kershaw πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 64 KB πŸ‘ 2 views

## Abstract ## Background Acetylcholinesterase inhibitors (AChEIs) can provide benefits at the cognitive, behavioral, and functional levels to patients with Alzheimer's disease (AD). With more AChEIs now available, treatment considerations may include whether the patient has had prior exposure to

One-year treatment of Alzheimer's diseas
One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other tests
✍ Alina Borkowska; Marzena Ziolkowska-Kochan; Janusz K. Rybakowski πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 67 KB

The aim of this study was to assess cognitive functioning measured by selected psychometric and neuropsychological tools in patients with Alzheimer's disease (AD) after 1-year treatment with acetylcholinesterase inhibitors. Seventy-six patients (22 male and 54 female) with a mild to moderate stage o